ANB004
ANB004 is a humanized monoclonal antibody inhibitor, targeting IL-17. ANB004 can be used for autoimmune and inflammatory diseases like multiple sclerosis and rheumatoid arthritis (RA) research[1][2].
Product Specifications
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Wang W, et al. Artificial Macrocycles as IL-17A/IL-17RA Antagonists. Medchemcomm. 2018 Jan 1;9 (1) :22-26. |[2]Iain M, et al. Method of treating tendinopathy using interleukin-17 (IL-17) antagonists. AU2024202601A1. 2024-07-18.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-17
More Discoveries
Explore Other Products
Browse additional items from our catalog
A09506-1-FITC 100 µg/Vial
Anti-GLYAT Antibody Picoband®, FITC Conjugate
Sign In for Pricing
View Details 
bs-3945R-PE 100 µL
Glucagon Receptor Polyclonal Antibody, PE Conjugated
Sign In for Pricing
View Details 
bs-5169R-PE 100 µL
Phospho-ATF2 (Ser322) Polyclonal Antibody, PE Conjugated
Sign In for Pricing
View Details MP0915X Each
Magic™ Membrane Protein Human OR52N4 (Olfactory receptor family 52 subfamily N member 4) for Antibody Discovery
Sign In for Pricing
View Details